tiprankstipranks
Trending News
More News >
VistaGen Therapeutics (VTGN)
NASDAQ:VTGN
US Market

Compare VistaGen Therapeutics (VTGN) vs. Competitors

Compare
1,172 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
VistaGen Therapeutics
$0.54
$23.13M
-0.34
-81.02%
0 Buy
5 Hold
0 Sell
Hold
MacroGenics
$1.93
$113.87M
-1.60
-39.20%
1 Buy
2 Hold
0 Sell
Moderate Buy
Ovid Therapeutics
$1.55
$201.79M
-3.03
122.86%
8 Buy
0 Hold
0 Sell
Strong Buy
Spero Therapeutics
$2.25
$125.64M
-2.83
151.72%
0 Buy
2 Hold
0 Sell
Hold
Inhibikase Therapeutics
$1.57
$192.81M
-2.75
-21.87%
5 Buy
0 Hold
0 Sell
Strong Buy
Surrozen
$22.08
$185.87M
-1.01
78.50%
3 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
VTGN
VistaGen Therapeutics
0.56
-2.33
-80.69%
MGNX
MacroGenics
1.83
-1.17
-39.00%
OVID
Ovid Therapeutics
1.56
0.90
135.29%
SPRO
Spero Therapeutics
2.19
1.33
154.65%
IKT
Inhibikase Therapeutics
1.50
-0.77
-33.92%
SRZN
Surrozen
21.55
9.95
85.73%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts